Check out our most popular compounded medications! Get Started
Budesonide 1 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient, Budesonide. These capsules are formulated with Methocel E4M, a controlled-release polymer, which allows for the gradual release of the medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance. Budesonide is a corticosteroid that is commonly used to treat a variety of disease states, including chronic obstructive pulmonary disease (COPD), asthma, and inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Budesonide 1 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to provide a controlled and prolonged release of the active ingredient, Budesonide. This formulation utilizes Methocel E4M, a type of controlled-release polymer, to encapsulate the medication. This innovative technology allows for the gradual release of the medication over an extended period of time, providing sustained therapeutic effects.
This slow-release mechanism offers several benefits. Firstly, it reduces the frequency of dosing, making it more convenient for patients. Secondly, it improves patient compliance, as the need for frequent dosing can often lead to missed doses. Lastly, by providing a steady and controlled release of the medication, it ensures a consistent therapeutic effect, avoiding the peaks and troughs often associated with immediate-release formulations.
Budesonide is a corticosteroid that is used to treat a variety of conditions. It works by reducing inflammation in the body, which can help to relieve symptoms in a range of disease states. These include chronic obstructive pulmonary disease (COPD), asthma, Crohn's disease, and ulcerative colitis. By reducing inflammation, Budesonide can help to alleviate symptoms such as shortness of breath, wheezing, and abdominal pain, improving the quality of life for patients with these conditions.
It's important to note that while Budesonide can help to manage symptoms, it is not a cure for these conditions. It should be used as part of a comprehensive treatment plan, under the guidance of a healthcare professional. As with any medication, it's important to take it as directed, and to discuss any potential side effects or interactions with your healthcare provider.
If you have any questions about the Budesonide 1 mg Slow Release (MEM4) Oral Capsules, or if you would like more information about how this formulation could benefit you or your patients, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
Budesonide is a corticosteroid that is used to treat a variety of conditions such as asthma, Crohn's disease, and ulcerative colitis. It works by reducing inflammation in the body, which can help to alleviate symptoms associated with these conditions. However, like all medications, Budesonide can interact with other drugs, which can affect how it works and increase the risk of side effects.
One of the most significant drug interactions to be aware of is with other corticosteroids. Taking Budesonide with other corticosteroids can increase the risk of side effects such as osteoporosis, cataracts, and an increased risk of infection. Therefore, it is important to inform your healthcare provider if you are taking any other corticosteroids.
Budesonide can also interact with certain antifungal medications, such as ketoconazole and itraconazole. These medications can increase the levels of Budesonide in the body, which can increase the risk of side effects. If you are taking an antifungal medication, your healthcare provider may need to adjust your dose of Budesonide.
Other medications that can interact with Budesonide include certain antibiotics, such as clarithromycin and erythromycin, as well as certain HIV medications, such as ritonavir and atazanavir. These medications can also increase the levels of Budesonide in the body, which can increase the risk of side effects.
It's also important to note that Budesonide can interact with grapefruit and grapefruit juice. Grapefruit can increase the levels of Budesonide in the body, which can increase the risk of side effects. Therefore, it is recommended to avoid grapefruit and grapefruit juice while taking Budesonide.
Lastly, Budesonide can interact with certain vaccines. Therefore, it is important to inform your healthcare provider if you are taking Budesonide before receiving any vaccines.
This is not a complete list of all possible drug interactions. Therefore, it is important to inform your healthcare provider of all the medications you are currently taking, including prescription and over-the-counter medications, vitamins, and herbal supplements. Your healthcare provider can provide you with a more complete list of possible drug interactions and can monitor you for them.
If you have any questions about Budesonide or its possible drug interactions, please do not hesitate to reach out to us. We are here to help and provide you with the information you need to make informed decisions about your health.
The Budesonide 1 mg Slow Release (MEM4) Oral Capsules are designed to provide a controlled and prolonged release of the active ingredient, Budesonide, over an extended period of time. This is achieved through the use of Methocel E4M, a type of controlled-release polymer, which encapsulates the medication and gradually releases it into the body.
Budesonide is a corticosteroid that works by reducing inflammation in the body. It is often used to treat conditions such as asthma, Crohn's disease, and ulcerative colitis, where inflammation plays a key role in the disease process. By delivering a steady dose of Budesonide over a prolonged period, these capsules can help to manage the symptoms of these conditions and improve the patient's quality of life.
The slow-release formulation of these capsules offers several benefits. Firstly, it provides sustained therapeutic effects, ensuring that the medication is delivered to the body at a steady rate. This can help to maintain a consistent level of the drug in the body, reducing the risk of peaks and troughs in the drug's concentration and thereby minimizing potential side effects.
Secondly, the slow-release formulation reduces the dosing frequency. This means that patients only need to take the medication once or twice a day, rather than multiple times throughout the day. This can improve patient compliance, as it is easier for patients to remember to take their medication and adhere to their treatment regimen.
Finally, the slow-release formulation can also improve the overall effectiveness of the medication. By ensuring a steady release of the drug, it can help to maintain a consistent level of the drug in the body, which can enhance the therapeutic effects and improve the management of the patient's condition.
If you have any questions about the Budesonide 1 mg Slow Release (MEM4) Oral Capsules, or if you would like more information about how this formulation works, please do not hesitate to reach out to us. We are always here to help and provide the information you need to make informed decisions about your health and treatment options.
Budesonide 1 mg Slow Release (MEM4) Oral Capsules are a medication formulated with Methocel E4M, a controlled-release polymer. It is designed to gradually release the encapsulated medication over an extended period of time, which offers a controlled and prolonged therapeutic effect coupled with reduced dosing frequency.
Methocel E4M is a type of controlled-release polymer utilized in certain medications. Its main function is to prolong the release of the active ingredient or medication inside the body, reducing the need for frequent dosing and improving patient compliance.
Slow release capsules like the Budesonide 1 mg Slow Release (MEM4) Oral Capsules offer various benefits such as sustained therapeutic effects over a longer duration of time and a reduced dosing frequency. Through this, there's less probability of missing doses and improved patient compliance.
Medications that require a controlled and prolonged release profile are suitable to be formulated as slow-release capsules. This generally includes medications that need to maintain certain therapeutic levels within the body for extended periods.
"MEM4" is usually a code or a batch number used for identification purposes; however, without further context, it could have a specific meaning designated by the healthcare facility or pharmaceutical manufacturer.
A controlled-release polymer like Methocel E4M works by gradually releasing the encapsulated active ingredient or the medication within the body over an extended period of time. This is achieved by controlling the dissolution or the breakdown of the capsule shell, thereby controlling the rate at which the active ingredient is released.
Yes, the frequency of dosage is typically reduced with slow-release capsules. The benefit of these capsules is that they gradually release medication over a period of time. This means that instead of taking medication multiple times a day, a patient could only need to take their medication once a day or every 12 hours, depending on the specific formulation.
Slow release capsules aid in improving patient compliance by reducing the frequency of dosage. Patients are more likely to adhere to their medication schedule when the number of doses per day is reduced. Furthermore, the slow release of the medication provides prolonged therapeutic effects, increasing the efficiency of the treatment.
Yes, a prescription from a qualified healthcare practitioner is generally required for Budesonide 1 mg Slow Release (MEM4) Oral Capsules, as it is typically utilized for specific medical conditions and should be used under medical supervision.
As these are slow-release capsules, the medication is not wholly released immediately upon ingestion. Instead, it is gradually released over a set, extended period of time. Consequently, you may not feel the effects immediately after ingestion, and it’s important to continue taking the medication as prescribed by your healthcare provider.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
